Latest News - Hologic

Top Corporates Hub

Hologic

HOLX | NASDAQ | United States
989
Rank
$17.15B
Market Cap
$4.03B
+$ 0.07B
+1.77%
Revenue
$1.04B
+$ 0.31B
+42.47%
Earnings
7.1K
Employees
How to Play Hologic Stock Post Q1 Earnings and Progress on Buyout?

16.02.2026 14:42

HOLX's $18.3B Blackstone-TPG buyout nears close after Q1 miss. With shares near a $76 cash offer, the upside for HOLX investors looks dim.

Read More

Is Wall Street Bullish or Bearish on Hologic Stock?

10.02.2026 13:57

Though Hologic has outperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Read More

Blackstone Q4 Earnings Call Highlights

30.01.2026 01:42

Blackstone (NYSE:BX) executives used the firm’s fourth-quarter and full-year 2025 investor call to highlight record financial results, a sharp pickup in fundraising, and early signs of a reopening in capital markets that could support higher realizations in 2026 and beyond. Record year for distribu

Read More

Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?

21.01.2026 17:10

Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Read More

Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings?

21.01.2026 12:51

HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift upcoming Q1 results.

Read More

HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now?

19.01.2026 12:52

Hologic and Stryker gear up for earnings with diagnostic wins, surgical growth and strategic moves shaping the medical device race.

Read More

Is It Time To Reassess Hologic (HOLX) After Recent Valuation Signals

18.01.2026 11:07

If you are wondering whether Hologic's share price still offers value or if most of the opportunity is already priced in, you are exactly who this breakdown is written for. The stock recently closed at US$74.98, with returns of 0.1% over the last week, 0.0% over the last month, 0.6% year to date and 7.5% over the past year, while the 3 year and 5 year returns sit at a 5.9% decline and 1.0% decline respectively. Recent company news has focused on Hologic's position in medical technology and...

Read More

Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening

13.01.2026 14:00

MARLBOROUGH, Mass., January 13, 2026--Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening

Read More

How Recent Analyst Moves Are Rewriting The Story For Hologic (NasdaqGS:HOLX)

13.01.2026 00:17

The latest update on Hologic centers on a very slight trim to the fair value estimate, from about US$76.50 to about US$76.42 per share. This keeps it closely aligned with the proposed acquisition terms that many Street targets now cluster around. Under the hood, the model has only minor tweaks to the discount rate, revenue growth input and other core assumptions. This lines up with how research firms are treating the deal price as the main reference point rather than reshaping their long term...

Read More

HOLX vs. SONVY: Which Stock Should Value Investors Buy Now?

08.01.2026 16:40

HOLX vs. SONVY: Which Stock Is the Better Value Option?

Read More

What You Need To Know Ahead of Hologic's Earnings Release

08.01.2026 11:44

Hologic is scheduled to release its first-quarter results soon, with analysts projecting single-digit growth in its bottom line figure.

Read More

Hologic Trading Near 52-Week High: How Should You Play the Stock?

05.01.2026 12:17

HOLX nears its 52-week high on diagnostics growth and AI adoption, while tariffs and challenges in China continue to pose risks.

Read More

3 Unpopular Stocks We Find Risky

30.12.2025 04:34

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Read More

Assessing Hologic (HOLX) Valuation After Its Recent 3-Month Share Price Climb

18.12.2025 13:08

Hologic (HOLX) has been quietly grinding higher, with shares up about 10% over the past 3 months, as investors warm to its steady revenue growth and improving profitability in women’s health diagnostics and devices. See our latest analysis for Hologic. Zooming out, Hologic’s roughly 10% 3 month share price return builds on a steadier uptrend this year, even as its 1 year total shareholder return remains modest. This suggests sentiment is improving but not euphoric at $74.93. If Hologic’s...

Read More

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

12.12.2025 14:00

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Read More

What Is Driving Hologic's Strength in the US Diagnostics Market?

12.12.2025 12:34

HOLX's Diagnostics gains accelerate as U.S. molecular testing drives growth and new Panther Fusion and Genius platform approvals widen its runway.

Read More

Is Hologic Stock Outperforming the Nasdaq?

12.12.2025 09:04

While Hologic has underperformed the Nasdaq over the past year, it has notably outperformed in recent months, but analysts still remain cautious about the stock’s prospects.

Read More

3 Cash-Producing Stocks We Approach with Caution

12.12.2025 04:35

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Read More

New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration

02.12.2025 13:10

MARLBOROUGH, Mass., December 02, 2025--New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test

Read More